A Nudge Towards Cardiovascular Health: Applications of Behavioral Economics for Primary and Secondary Cardiovascular Prevention

被引:7
|
作者
Adusumalli, Srinath [1 ,2 ,3 ]
Aragam, Gowri [4 ,5 ]
Patel, Mitesh [1 ,3 ,6 ,7 ]
机构
[1] Univ Penn, Perelman Sch Med, PCAM South Pavil 11-139,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Div Cardiovasc Med, PCAM South Pavil 11-139,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[3] Univ Penn, Penn Med Nudge Unit, PCAM South Pavil 11-139,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[4] Stanford Univ, Dept Psychiat, 1520 Page Mill Rd, Palo Alto, CA 94304 USA
[5] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA
[6] Univ Penn Wharton Sch, PCAM South Pavil 11-139,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[7] Corporal Michael J Crescenz Vet Affairs Med Ctr, PCAM South Pavil 14-176,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA
关键词
Behavioral economics; Behavior change; Prevention; Digital health;
D O I
10.1007/s11936-020-00824-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review Despite robust development of effective behavioral and medical therapies in cardiovascular medicine, in many cases, patient and provider implementation of those therapies has been suboptimal. Ultimately, the implementation of those therapies relies upon one final common pathway: human behavior. Principles from the field of behavioral economics can be used to nudge patients and healthcare providers towards better healthcare decision-making. This review will focus on how the field of behavioral economics can inform the delivery of primary and secondary cardiovascular prevention interventions. Recent Findings Behavioral economics principles such as loss-framing, social norms, and choice architecture can be applied to successfully and sustainably change patient and provider behavior. These behavior changes can be potentiated by the use of electronic tools such as wearable activity trackers and electronic health records. Human behavior change is key to promotion of primary and secondary cardiovascular prevention. As our understanding of how to apply principles from behavioral economics develops, and as we apply those principles in a more targeted way, they will become even more powerful tools to promote positive clinical outcomes in patients with cardiovascular disease.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Platelet inhibitors in primary and secondary prevention of cardiovascular disease
    Huber, K.
    Jaeger, B.
    Kaufmann, C. C.
    JOURNAL FUR KARDIOLOGIE, 2019, 26 (11-12): : 312 - 316
  • [22] A telemonitoring program for primary and secondary prevention of cardiovascular disease
    Lupi, L.
    Glisenti, F.
    Castiello, A.
    Visco, E.
    Papa, I.
    Dinatolo, E.
    Arabia, G. M.
    Nodari, S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 855 - 855
  • [23] A telemonitoring program for primary and secondary prevention of cardiovascular disease
    Rocco, E.
    Villa, C.
    Lupi, L.
    Triggiani, M.
    Milesi, G.
    Berlinghieri, N.
    Manerba, A.
    Papa, I.
    Dasseni, N.
    Glisenti, F.
    Nodari, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1042 - 1043
  • [24] A Telemonitoring Program for Primary and Secondary Prevention of Cardiovascular Disease
    Nodari, Savina
    Lupi, Laura
    Glisenti, Fulvio
    Gensini, Gianfranco
    Papa, Ilaria
    Piazzani, Mariangela
    Fabbricatore, Davide
    Arabia, Gianmarco
    Gabbrielli, Francesco
    CIRCULATION, 2018, 138
  • [25] Possibilities of Ramipril in Primary and Secondary Prevention of Cardiovascular Diseases
    Tkacheva, O. N.
    Sharashkina, N. V.
    KARDIOLOGIYA, 2010, 50 (08) : 63 - 66
  • [26] Role of ASA in the primary and secondary prevention of cardiovascular events
    Casado-Arroyo, Ruben
    Bayrak, Fatih
    Sarkozy, Andrea
    Chierchia, Gian-Battista
    de Asmundis, Carlo
    Brugada, Pedro
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (02) : 113 - 123
  • [27] Atorvastatin Efficacy in the Primary and Secondary Prevention of Cardiovascular Events
    Marcello Arca
    Achille Gaspardone
    Drugs, 2007, 67 : 29 - 42
  • [28] Mediterranean Diet for primary and secondary Prevention of cardiovascular Diseases
    Schwingshackl, Lukas
    ERNAHRUNGS UMSCHAU, 2019, 66 (12): : M731 - M733
  • [29] Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events
    Arca, Marcello
    Gaspardone, Achille
    DRUGS, 2007, 67 (Suppl 1) : 29 - 42
  • [30] Cardiovascular secondary prevention
    Rupprecht, H. -J.
    CLINICAL RESEARCH IN CARDIOLOGY, 2006, 95 : 1 - 5